Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By ...

Colorectal cancer is a high disease burden cancer and is the second leading cause of cancer deaths worldwide. The first-line treatment option is surgical resection of cancerous tissue. However, the ...

Although penile cancer represents less than 1% of male malignancies, it carries substantial physical and psychological burden, with a five-year survival rate near 50%. Around half of Penile squamous ...

Metastatic colorectal cancer (mCRC) remains a leading cause of cancer-related mortality worldwide. While significant advances have been achieved with ...

RESPIRATORY viral infections are emerging as a potential driver of lung cancer development, with new findings suggesting that ...

Scientists have unveiled two major innovations in lung cancer care: a remote, battery-free airway stent monitoring device from Vanderbilt University and a highly accurate immune-mapping model from VIB ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

The landscape of breast cancer research is undergoing a significant shift, moving toward complex, combination strategies designed to overcome the body’s own immune suppression. Keith Knutson, a cancer ...

A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...

The oncolytic virus immunotherapy market presents opportunities with three approved therapies, extensive clinical trial pipelines, and innovative research by biotechnology and pharmaceutical companies ...